Leidos’ MACH-TB program successfully completes 1st test launch

Leidos’ MACH-TB program successfully completes 1st test launch

WALLOPS ISLAND, VA (June 19, 2023) – Leidos (NYSE: LDOS), a Fortune 500® technology, engineering and science solutions and service leader, announced its Dynetics team has successfully completed a large-scale test for its MACH-TB program. The Multi-Service Advanced Capability Hypersonic Test Bed (MACH-TB) program is meant to increase the speed of testing for all commercially available hypersonic systems. The program also called for the creation of an experimental glide body (EGB) that will allow the team to gather data on and validate performance of hypersonic glide body components.

“This successful test has demonstrated first hypersonic insertion of a payload from a commercial launch vehicle and the team is ready to move forward into the next phase of this program,” said Leidos CEO Tom Bell. “It took our MACH-TB team only 49 days to create this innovative technology demonstration, which highlights our ability to deliver on promises.”

The inaugural launch took place on June 17 at 9:24 p.m. UTC from Rocket Lab’s Launch Complex 2 at Virginia’s Mid-Atlantic Regional Spaceport within NASA’s Wallops Flight Facility. Rocket Lab was selected by Leidos to provide hypersonic test launch capabilities under the MACH-TB project awarded by Naval Surface Warfare Center (NSWC) Crane through the Strategic and Spectrum Missions Advanced Resilient Trusted Systems (S2MARTS) Other Transaction Authority (OTA) vehicle on behalf of the U.S. Department of Defense.

“Today marks a significant milestone in our commitment to pushing forward the boundaries of hypersonic innovation,” said Dr. Angie Lewis, NSWC Crane Technical Director. “Our approach will accelerate progress so that the nation has the right capabilities to counter and address the threat landscape today and throughout this decisive decade.”

The next phase of the program will expand upon this successful test to develop additional opportunities to increase the U.S.’ cadence of hypersonic flight testing in support of technology maturation.

“This cutting-edge technology has yet to be developed and is breaking new ground for an important and necessary sector of our industry,” concluded Bell.” Leidos is proud to manufacture a test bed that can provide the U.S. with an advantage in the great power competition.”

About Leidos

Leidos is a Fortune 500® technology, engineering, and science solutions and services leader working to solve the world’s toughest challenges in the defense, intelligence, civil, and health markets. The company’s 45,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $14.4 billion for the fiscal year ended December 30, 2022. For more information, visit www.Leidos.com.

About Dynetics

Dynetics, a wholly owned subsidiary of Leidos, provides responsive, cost-effective engineering, scientific, IT solutions to national security, cybersecurity, space and critical infrastructure sectors. Our portfolio features highly specialized technical services and a range of software and hardware products, including components, subsystems and complex end-to-end systems. The company of more than 3,000 employees is based in Huntsville, Alabama, and has offices throughout the U.S. For more information, visit www.dynetics.com.

Certain statements in this announcement constitute “forward-looking statements” within the meaning of the rules and regulations of the U.S. Securities and Exchange Commission (SEC). These statements are based on management’s current beliefs and expectations and are subject to significant risks and uncertainties. These statements are not guarantees of future results or occurrences. A number of factors could cause our actual results, performance, achievements, or industry results to be different from the results, performance, or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, the “Risk Factors” set forth in Leidos’ Annual Report on Form 10-K for the fiscal year ended December 30, 2022, and other such filings that Leidos makes with the SEC from time to time.  Readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. Leidos does not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statements were made.